Joseph K. Schachle - 23 Oct 2026 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Reporting relationship: Chief Operating Officer
Issuer ticker: IRD
Reported as of: 23 Oct 2026
Net transaction value: -$16,994
SEC form: 4
Accepted by SEC: 27 Oct 2026, 16:47:42 UTC
Prior SEC filing: 27 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy Rabourn, by Power of Attorney

Filing notes and source

Key filing fact

Joseph K. Schachle filed Form 4 for Opus Genetics, Inc. (IRD) on 27 Oct 2026.

Key facts

This page summarizes Joseph K. Schachle's Form 4 filing for Opus Genetics, Inc. (IRD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Oct 2026, 16:47.

Change

Previous filing in this sequence was filed on 27 Jul 2026.
Current net transaction value: -$16,994.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001145914 Primary reporting owner

SCHACHLE JOSEPH K

Relationship: Chief Operating Officer
Address: C/O OPUS GENETICS, INC., 8 DAVIS DRIVE, SUITE 220, DURHAM
Signature: /s/ Amy Rabourn, by Power of Attorney
Signature date: 27 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRD transaction

Common Stock

Sale

Transaction value: -$16,994
Shares: -4,767
Change %: -1.6%
Price: $3.56
Shares after: 286,673
Date: 23 Oct 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Issuer to satisfy tax withholding obligations that arose in connection with the vesting and settlement of restricted stock units. This transaction does not represent a discretionary trade by the Reporting Person.